From: Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer
 | Category | No. (%) |
---|---|---|
Race and ethnicity | Non-Hispanic White | 55 (77.5) |
Hispanic/Latina | 11 (15.5) | |
Asian | 5 (7.0) | |
Median age of diagnosis (years) | 58 | Â |
Age at diagnosis (years) |  < 50 | 7 (9.9) |
50–69 | 53 (74.6) | |
 ≥ 70 | 11 (15.5) | |
Median overall survival (months) | 37.8 | Â |
Median RFSa (months) | 16.5 | Â |
Median follow-upb (months) | 55.8 | Â |
Stage | IIIA-IIIC | 62 (87.3) |
IV | 9 (12.7) | |
Debulking status | Optimal | 61 (85.9) |
Suboptimal | 7 (9.9) | |
Unable to debulk | 1 (1.4) | |
Unknown | 2 (2.8) | |
Chemotherapy therapy | Adjuvant | 57 (80.3) |
Neoadjuvant | 14 (19.7) | |
Chemotherapy delivery | Intraperitoneal | 28 (39.4) |
Intravenous | 43 (60.6) | |
Tumors investigated | Primary | 64 |
Metastatic | 50 | |
Tumors per patient | 1 | 44 |
2 | 17 | |
 ≥ 3 | 10 |